WhiteSwell Medical

Acute Decompensated Heart Failure Treatment

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in September 2014, WhiteSwell Medical operates with 11–50 employees. The company has raised $30 million across one funding round from two investors. In December 2018, WhiteSwell Medical secured $30 million in funding.

Business overview

WhiteSwell Medical is a science-driven company focused on improving the treatment of acute decompensated heart failure (ADHF), a major cause of repeat hospitalizations. The company is developing a minimally invasive, catheter-based approach designed to enhance the natural fluid-removal process of the lymphatic system, thereby more efficiently removing excess interstitial fluid in ADHF patients. It operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In January 2022, WhiteSwell Medical expanded its senior management team with experienced executives. This move signals a strategic strengthening of leadership, likely in preparation for further development, clinical trials, or market entry for its catheter-based ADHF treatment. For investors, this indicates a company building out its operational capabilities and expertise to advance its innovative medical device.

Log in to access full profile

Company Intelligence Q&A

What is WhiteSwell Medical's primary focus?
WhiteSwell Medical is dedicated to improving the treatment of acute decompensated heart failure (ADHF) through a minimally invasive, catheter-based approach that enhances the lymphatic system's natural fluid-removal process.
When was WhiteSwell Medical founded?
WhiteSwell Medical was founded in September 2014.
How much funding has WhiteSwell Medical raised?
WhiteSwell Medical has raised a total of $30 million. This funding was secured in a single round in December 2018.
Which investors participated in WhiteSwell Medical's funding round?
In December 2018, WhiteSwell Medical secured $30 million in funding from RA Capital Management and InCube Ventures.
What recent strategic development has WhiteSwell Medical undertaken?
In January 2022, WhiteSwell Medical added experienced executives to its senior management team, strengthening its leadership for future growth and operational advancements.
Log in to access full profile